Haleon (LON:HLN) Stock Price Up 0.3% – Time to Buy?

Haleon plc (LON:HLN) rose 0.3% on Thursday . The stock traded as high as GBX 391.80 ($4.93) and last traded at GBX 391.69 ($4.93). Approximately 10,667,455 shares were traded during mid-day trading, a decline of 61% from the average daily volume of 27,116,525 shares. The stock had previously closed at GBX 390.50 ($4.92).

Haleon Stock Performance

The company has a market capitalization of £34.69 billion, a price-to-earnings ratio of 32.32, a P/E/G ratio of 1.49 and a beta of 0.19. The company has a debt-to-equity ratio of 53.36, a quick ratio of 0.93 and a current ratio of 0.84. The firm has a 50-day simple moving average of GBX 377.53 and a two-hundred day simple moving average of GBX 377.16.

Insider Buying and Selling at Haleon

In other news, insider Dawn Allen sold 74,679 shares of the business’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of GBX 372 ($4.68), for a total transaction of £277,805.88 ($349,661.27). 10.74% of the stock is currently owned by corporate insiders.

Haleon Company Profile

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.